Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
This company is a manufacturer and exporter of all types of pharmaceutical formulations like tablets, capsules, dry powder, syrups, injections, ointments and betalactams etc.
Gpax Pharmaceuticals Private Limited, is an unlisted private company incorporated on 30 September, 2014. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 17.69 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Amit Rajan
Shareholder
|
03264797 | 12 years |
| Director | Vijaykumar Vazakttuvaliya Raghavan Nair
Shareholder
|
00261386 | 12 years |
| Director | Rabi Narayan Nayak
Shareholder
|
01650096 | 12 years |
| Director | Thykoottathil Rajan Matthews
Shareholder
|
01654813 | 12 years |
| Director | Anuj Somchand Bhagwanji Shah
Shareholder
|
05256492 | 2 years |
| Director | Vikash Naresh Shah | 07134819 | 2 years |
| Director | Bharat Kakubhai Katariya | 10420979 | 2 years |
| Director | Shailesh Kakulal Kataria | 10420981 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
NKGSB CO.OP. BANK LTD.
No. of Loans: 2
Total Amount : 8.8 cr
NKGSB CO. OP. BANK LTD.
No. of Loans: 3
Total Amount : 6.0 cr
NKGSB CO OP BANK LIMITED
No. of Loans: 1
Total Amount : 2.5 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| LAVINIA LIFE SCIENCES PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| AGAM AND GEM LABORATORIES PRIVATE LIMITED |
Active
|
1.0 Cr | 3 | Daman and Diu |
| CELOGEN PHARMA PRIVATE LIMITED |
Active
|
4.8 Cr | 3 | Maharashtra |
| CELOGEN LIFESCIENCE & TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 4 | Maharashtra |
| CELOGEN LABORATORIES PRIVATE LIMITED |
Active
|
10.0 L | 3 | Maharashtra |
| NEOTRIC PHARMACEUTICAL LLP |
Active
|
1.0 L | 1 | Goa |
| PROSFORA TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.9 L | 1 | Maharashtra |
Read more
The incorporation date of GPAX PHARMACEUTICALS PRIVATE LIMITED is 30 September, 2014
The authorized share capital of GPAX PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 20.0 Cr.
The paid-up capital of GPAX PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 17.7 Cr.
The registered address of GPAX PHARMACEUTICALS PRIVATE LIMITED is OFF B-106, TECHNO CITY, PL X-4/1, X-4/2, TTC AREA, MIDC, MAHAPE, Thane, NAVI MUMBAI, Maharashtra, India, 400701 - 400701
The CIN number of GPAX PHARMACEUTICALS PRIVATE LIMITED is U24233MH2014PTC258452.